Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 438 results found. Search for [ Serum Institute of India vaccine trials ]

Results 20 to 40 of 438
BusinessToday.In
May 24, 2021
The company is aiming to submit the emergency use application by June. \"We still think we should be able to submit (the vaccine for emergency use authorisation) in May,\" MD Sharvil Patel said


PTI
May 21, 2021
The Centre will also take up with Moderna, Johnson and Johnson and other vaccine makers the issue of granting voluntary licence to third-party manufacturers in India on transfer of technology basis


BusinessToday.In
New Delhi, May 19, 2021
COVID-19 vaccines that are available in the United States are effective against the deadly variant that was first detected in India, top US health officials said on Tuesday; Amidst the debate over shortage of COVID-19 vaccines in the country and export of vaccines from India, Serum Institute of India (SII) on Tuesday said the company never exported vaccines at the cost of people in India, and it remains committed to the country's vaccination programme; Hospitals in Delhi have reported a rise in the number of back fungus cases or mucormycosis among people recovering from COVID-19 during the second wave and it could be ascribed to \"irrational\" use of steroids at home without consulting a doctor, medical experts said on Tuesday. Watch this and more on News Blast.


Rashi Bisaria
New Delhi, May 19, 2021
India watching Singapore COVID-19 situation; precautions in place against new strain: Hardeep Puri Aviation Minister Hardeep Singh Puri Tuesday said the Centre is taking all precautions and keeping an eye on the situation in Singapore after Delhi Chief Minister Arvind Kejriwal appealed to it to cancel all flights with the city-state as a \"very dangerous\" coronavirus strain has been detected there. US COVID-19 vaccines effective against B.1.617 variant found in India COVID-19 vaccines ...


BusinessToday.In
May 18, 2021
This would be the first time in the country when a COVID-19 vaccine will be tested on children. The clinical trials will involve two COVID vaccine shots injected on day 0 and day 28 and will take place at several sites -- AIIMS, Delhi; AIIMS, Patna; and Meditrina Institute of Medical Sciences, Nagpur


PTI
May 18, 2021
During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply


BusinessToday.In
May 17, 2021
The anti-Covid oral drug has been developed by DRDO's leading laboratory -- Institute of Nuclear Medicine and Allied Sciences -- in collaboration with Dr Reddy's Laboratories


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


BusinessToday.In
May 16, 2021
Russian Ambassador to India Nikolay Kudashev termed the delivery of the second consignment of Sputnik V vaccine in the country \"very timely\"


Shailendra Shukla
New Delhi, May 15, 2021
Extension of gap between Covishield doses 'reasonable approach', says Dr FauciAmid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'. He said that if one is in a situation that India finds itself in currently, then one would have to try and figure out other ways to get as many as possible vaccinated. The comments come after the government announced on Thursday that the gap betwe...


BusinessToday.In
May 13, 2021
Bharat Biotech has been producing Covaxin at its Biosafety Level-3 (BSL-3) facilities in Hyderabad and Bengaluru, where production capacity had been enhanced in a step-wise manner


BusinessToday.In
May 13, 2021
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers


BusinessToday.In
New Delhi, May 12, 2021
Prime Minister Narendra Modi will not travel to the UK to attend the G-7 summit in June due to the coronavirus situation in the country; To strengthen corporate governance practices and disclosure requirements, Sebi has notified new rules, including that top 1,000 listed firms will have to formulate a dividend distribution policy; Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. Watch this and more news on News Blast. BT podcast : 'Outright lies', says China on reports of weaponising COVID-19 in 2015


Rashi Bisaria
New Delhi, May 12, 2021
'Outright lies': China on reports that its military scientists probed weaponising COVID-19 in 2015China on Monday termed as \"outright lies\", the media reports that its military scientists investigated weaponising coronaviruses five years before the COVID-19 pandemic outbreak and said it is an attempt by the US to smear the country. The US State Department reportedly obtained the \"bombshell\" documents, which were written by Chinese military scientists and senior public health officials in ...


PTI
May 9, 2021
Tata Sons President (Infrastructure, Defence, Aerospace and Global Corporate Affairs) Banmali Agrawala said people need to be vaccinated faster but safely as well


PTI
May 8, 2021
While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues


Vivek Dubey
May 6, 2021
\"The cost of the Sputnik Light vaccine globally will be less than $10 [around Rs 730], while it has simple storage requirements, at 2-8 degrees Celsius, which provide for easy logistics\"


PTI
May 4, 2021
The investments confirmed by Downing Street on Monday evening form part of an Enhanced Trade Partnership (ETP), which will set the ambition to double the value of UK-India trade by 2030


BusinessToday.In
May 4, 2021
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK


PTI
May 4, 2021
The investments confirmed by Downing Street form part of an Enhanced Trade Partnership (ETP), which UK PM Boris Johnson and his Indian counterpart Narendra Modi will formally sign off during their talks


PAGES 2 OF 22  12345